Screener
Jazz Pharmaceuticals JAZZ Compensation and benefits
Compensation and benefits at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The source filing: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001232524-26-000025
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Net income (loss) | $293.1 | $(92.5) |
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||
| Intangible asset amortization | 172.3 | 154.4 |
| Share-based compensation | 74.5 | 67.7 |
| Acquisition accounting inventory fair value step-up adjustment | 37.5 | 29.9 |
| Provision for losses on accounts receivable and inventory | 14.2 | 5.3 |
| Depreciation | 9.1 | 10.4 |
| Non-cash interest expense | 4.7 | 17.1 |
Item 1.Financial Statements
FAQ
- What is Jazz Pharmaceuticals's compensation and benefits?
- Jazz Pharmaceuticals (JAZZ) reported compensation and benefits of $74.5M in Q1 2026.
- How has Jazz Pharmaceuticals's compensation and benefits changed year-over-year?
- Jazz Pharmaceuticals's compensation and benefits increased by 10.0% year-over-year, from $67.7M to $74.5M.
- What is the long-term trend for Jazz Pharmaceuticals's compensation and benefits?
- Over 2 years (2021 to 2025), Jazz Pharmaceuticals's compensation and benefits has grown at a 24.1% compound annual growth rate (CAGR), from $189.01M to $291.13M.
- What does compensation and benefits mean?
- Total employee-related costs including salaries, wages, bonuses, commissions, stock-based compensation, health insurance, retirement contributions, and payroll taxes.
Ask your AI about Jazz Pharmaceuticals's compensation and benefits.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude